Profile data is unavailable for this security.
About the company
Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
- Revenue in JPY (TTM)104.00m
- Net income in JPY-2.22bn
- Incorporated2011
- Employees65.00
- LocationHealios KK11F, Seiroka Tower, 8-1, Akashi-choCHIYODA-KU 100-0006JapanJPN
- Phone+81 345908006
- Fax+81 335448760
- Websitehttps://www.healios.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nano Holdings Inc | 156.34m | -887.50m | 11.68bn | 20.00 | -- | 4.23 | -- | 74.69 | -12.46 | -12.46 | 2.19 | 36.19 | 0.0308 | 44.49 | 5.29 | 7,817,050.00 | -17.51 | -23.68 | -22.01 | -25.37 | 89.54 | 82.69 | -567.67 | -746.83 | 5.93 | -- | 0.4829 | -- | -19.92 | -27.80 | -7.10 | -- | -- | -- |
| Kidswell Bio Corp | 7.06bn | 23.83m | 12.85bn | 37.00 | 226.25 | 6.67 | 525.06 | 1.82 | 1.14 | 1.14 | 150.11 | 38.83 | 1.30 | 6.38 | 23.34 | 190,934,200.00 | 0.4375 | -16.75 | 0.678 | -27.06 | 27.45 | 47.46 | 0.3374 | -28.29 | 2.76 | -- | 0.5768 | -- | 109.03 | 36.37 | 98.51 | -- | 27.20 | -- |
| Pharma Foods International Co., Ltd. | 66.38bn | -1.88bn | 18.99bn | 613.00 | -- | 2.01 | -- | 0.2861 | -64.99 | -64.99 | 2,293.41 | 324.90 | 2.02 | 1.70 | 15.01 | 108,280,600.00 | -5.74 | 6.92 | -16.01 | 18.90 | 80.32 | 80.70 | -2.84 | 3.34 | 0.6512 | -8.21 | 0.6151 | 33.24 | 5.01 | 33.56 | -88.52 | -11.84 | -0.161 | 24.08 |
| AnGes Inc | 874.12m | -5.23bn | 23.74bn | 55.00 | -- | 7.59 | -- | 27.16 | -15.21 | -15.21 | 2.46 | 7.91 | 0.1735 | 0.3487 | 8.45 | -- | -103.74 | -49.52 | -189.41 | -59.16 | 36.65 | 31.53 | -597.83 | -3,839.32 | 1.18 | -23.87 | 0.0174 | -- | 35.81 | 85.31 | 81.42 | -- | -29.27 | -- |
| Heartseed Inc | -100.00bn | -100.00bn | 45.49bn | 39.00 | -- | 6.32 | -- | -- | -- | -- | -- | 314.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.15 | -- | 0.00004 | -- | -- | -- | -- | -- | -- | -- |
| Healios KK | 104.00m | -2.22bn | 51.57bn | 65.00 | -- | 9.04 | -- | 495.87 | -25.70 | -25.70 | 0.9661 | 42.25 | 0.0067 | -- | 0.4952 | -- | -14.27 | -23.01 | -18.09 | -30.33 | -109.62 | -- | -2,143.27 | -2,221.73 | -- | -- | 0.5993 | -- | -81.43 | 30.96 | 47.65 | -- | -11.70 | -- |
| Shin Nippon Biomedical Laboratories Ltd | 31.37bn | 3.99bn | 69.90bn | 1.44k | 17.52 | 1.32 | 9.82 | 2.23 | 95.84 | 95.84 | 753.61 | 1,269.67 | 0.2983 | 1.01 | 5.59 | 21,848,400.00 | 3.73 | 9.90 | 5.31 | 14.82 | 51.59 | 52.68 | 12.50 | 23.35 | 0.6308 | -- | 0.4383 | 30.49 | 22.55 | 17.36 | -10.96 | 14.07 | 54.79 | 58.49 |
| 3-D Matrix Ltd | 8.47bn | 6.47m | 73.58bn | 114.00 | -- | 18.45 | 96.11 | 8.69 | -2.67 | -2.67 | 71.61 | 32.90 | 1.25 | 0.9849 | 4.61 | 74,276,300.00 | 0.0958 | -35.52 | 0.1222 | -46.12 | 68.67 | 59.66 | 0.0764 | -55.66 | 2.53 | -- | 0.2619 | -- | 51.11 | 59.47 | -878.94 | -- | -7.64 | -- |
| Takara Bio Inc | 44.15bn | -7.20bn | 114.52bn | 1.78k | -- | 1.13 | -- | 2.59 | -59.79 | -59.79 | 366.64 | 839.16 | 0.3535 | 1.48 | 5.49 | 24,816,750.00 | -5.73 | 8.66 | -6.12 | 9.70 | 53.99 | 63.76 | -16.20 | 17.16 | 3.83 | -4.82 | 0.0898 | 31.40 | 3.53 | 5.44 | -29.59 | -22.88 | 20.46 | 16.27 |
| GNI Group Ltd | 26.84bn | -4.41bn | 143.66bn | 867.00 | -- | 2.86 | -- | 5.35 | -80.69 | -80.69 | 511.58 | 900.92 | 0.3447 | 2.18 | 4.01 | -- | -9.40 | 0.5414 | -11.37 | 0.6475 | 74.49 | 80.97 | -27.26 | 1.28 | 3.79 | -2.99 | 0.0941 | -- | 13.67 | 22.39 | -501.65 | -- | 34.24 | -- |
| SanBio Co Ltd | 0.00 | -3.44bn | 176.04bn | 29.00 | -- | 330.15 | -- | -- | -48.26 | -48.26 | 0.00 | 6.83 | 0.00 | -- | -- | 0.00 | -138.65 | -47.32 | -177.12 | -57.01 | -- | -- | -- | -- | -- | -12.42 | 0.725 | -- | -- | -- | -9.02 | -- | -46.04 | -- |
| Peptidream Inc | 18.52bn | -3.75bn | 203.92bn | 621.00 | -- | 3.93 | -- | 11.01 | -28.99 | -28.99 | 143.24 | 398.78 | 0.2182 | 3.75 | 3.32 | -- | -4.42 | 8.02 | -5.86 | 9.72 | 40.61 | 64.82 | -20.24 | 18.77 | 1.53 | -16.77 | 0.2485 | 0.00 | -60.32 | 9.66 | -124.97 | -- | 24.52 | -- |
Data as of Feb 17 2026. Currency figures normalised to Healios KK's reporting currency: Japanese Yen JPY
24.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Athos Capital Ltd.as of 13 Aug 2025 | 18.71m | 16.21% |
| FIL Investments (Japan) Ltd.as of 15 Apr 2025 | 5.36m | 4.65% |
| FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 2025 | 2.18m | 1.89% |
| FIL Pensions Managementas of 30 Jun 2025 | 1.10m | 0.95% |
| Maven Investment Partners Ltd.as of 13 May 2025 | 504.00k | 0.44% |
| Simplex Asset Management Co., Ltd.as of 05 Feb 2026 | 153.60k | 0.13% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 4.40k | 0.00% |
| JPMorgan Asset Management (Japan) Ltd.as of 25 Apr 2024 | 0.00 | 0.00% |
| Meiji Yasuda Asset Management Co. Ltd.as of 15 Feb 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
